Ming-Ling Kuo

Title: Innovations of Ming-Ling Kuo in Gene Transfer Technology.

Introduction

Ming-Ling Kuo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of gene transfer technology, particularly in the efficient introduction of exogenous genes into primary lymphocytes. His work has implications for advancements in medical research and therapeutic applications.

Latest Patents

Ming-Ling Kuo holds a patent titled "Efficient gene transfer into primary lymphocytes obviating the need for." This invention pertains to a method for efficiently introducing exogenous genes into primary lymphoid cells without drug selection. The process involves several steps, including deriving a retroviral vector and a helper cell combination, isolating a lymphoid cell subpopulation, and co-cultivating the lymphoid subpopulation with a virus-producing cell line. The invention results in a population of transfected lymphocytes, with greater than about 90% of the lymphocytes containing a provirus. He has 1 patent to his name.

Career Highlights

Ming-Ling Kuo is affiliated with the University of Medicine and Dentistry of New Jersey. His research focuses on innovative methods that enhance gene transfer efficiency, which is crucial for various applications in immunology and gene therapy.

Collaborations

Ming-Ling Kuo has collaborated with notable colleagues, including Joseph P Dougherty and Natalie Sutkowski. Their combined expertise contributes to the advancement of research in gene transfer technologies.

Conclusion

Ming-Ling Kuo's innovative work in gene transfer technology represents a significant advancement in the field. His contributions are poised to impact future research and therapeutic strategies in medicine.